The estimated Net Worth of Walter V Klemp is at least $2.32 Million dollars as of 2 July 2024. Mr. Klemp owns over 982 units of Soliton stock worth over $1,293,270 and over the last 7 years he sold SOLY stock worth over $170,000. In addition, he makes $860,458 as Executive Chairman of the Board and Co-Founder at Soliton.
Sign up
Mr. Klemp SOLY stock SEC Form 4 insiders trading
Walter has made over 20 trades of the Soliton stock since 2017, according to the Form 4 filled with the SEC. Most recently he exercised 982 units of SOLY stock worth $22,174 on 2 July 2024.
The largest trade he's ever made was buying 188,404 units of Soliton stock on 26 December 2023 worth over $129,999. On average, Walter trades about 24,596 units every 84 days since 2017. As of 2 July 2024 he still owns at least 57,275 units of Soliton stock.
You can see the complete history of Mr. Klemp stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Walter Klemp biography
Walter V. Klemp serves as Executive Chairman of the Board, Co-Founder of the Company. Mr. Klemp is a co-founder of our company and has served as our executive chairman since July 2018. He previously served as our Chief Executive Officer. From 2006 until 2016, Mr. Klemp has served as the chairman, co-founder and part-time chief executive officer of Moleculin, LLC, and since 2016, Mr. Klemp has served as chairman and chief executive officer of Moleculin Biotech, Inc., a clinical stage pharmaceutical company focused on the development of oncology drug candidates. Mr. Klemp served as president and chief executive officer of Zeno Corporation from 2004 to April 2011, where he developed and marketed dermatology devices from concept through FDA approval and market launch. From 1987 to 2000, Mr. Klemp served as chief executive officer and chairman of Drypers Corporation, a publicly traded multinational consumer products company that was listed as #1 on the INC 500 List of America’s Fastest Growing Companies. Mr. Klemp earned a B.A. degree from Lewis & Clark. Mr. Klemp currently provides services as needed by us, which we estimate does not exceed 10 hours per week.
What is the salary of Walter Klemp?
As the Executive Chairman of the Board and Co-Founder of Soliton, the total compensation of Walter Klemp at Soliton is $860,458. There are 1 executives at Soliton getting paid more, with Christopher Capelli having the highest compensation of $1,111,190.
How old is Walter Klemp?
Walter Klemp is 59, he's been the Executive Chairman of the Board and Co-Founder of Soliton since 2018. There are 1 older and 4 younger executives at Soliton. The oldest executive at Soliton, Inc. is Joe Tanner, 72, who is the Chief Operating Officer.
What's Walter Klemp's mailing address?
Walter's mailing address filed with the SEC is C/O MOLECULIN BIOTECH, INC., 5300 MEMORIAL DR., SUITE 950, HOUSTON, TX, 77007.
Insiders trading at Soliton
Over the last 5 years, insiders at Soliton have traded over $0 worth of Soliton stock and bought 632,904 units worth $999,992 . The most active insiders traders include Walter V Klemp, Ventures Llc Remeditex, and Jonathan P. Foster. On average, Soliton executives and independent directors trade stock every 126 days with the average trade being worth of $4,763,657. The most recent stock trade was executed by Ventures Llc Remeditex on 30 June 2020, trading 120,481 units of SOLY stock currently worth $999,992.
What does Soliton do?
Soliton, Inc., a medical device company, develops and commercializes products using a proprietary rapid acoustic pulse technology platform. It is developing a product for the removal of tattoos. The company was founded in 2012 and is headquartered in Houston, Texas.
What does Soliton's logo look like?
Complete history of Mr. Klemp stock trades at Moleculin Biotech Inc and Soliton
Soliton executives and stock owners
Soliton executives and other stock owners filed with the SEC include:
-
Christopher Capelli,
Vice Chairman of the Board, Chief Scientific Officer -
Walter Klemp,
Executive Chairman of the Board, Co-Founder -
Lori Bisson,
Chief Financial Officer -
Joe Tanner,
Chief Operating Officer -
Jonathan Foster,
Independent Director -
Bradley Hauser,
President, Chief Executive Officer -
Danika Harrison,
Independent Director -
Kaitlyn Brosco,
IR Contact Officer -
Michael Kaminer,
Independent Director -
Niquette Hunt,
Independent Director -
Ventures Llc Remeditex,
10% owner